Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Biochimica Et Biophysica Acta. General Subjects|August 6, 2018
GAPDH with NAD+-binding site mutation competitively inhibits the wild-type and affects glucose metabolism in cancerRani Kunjithapatham, Shanmugasundaram Ganapathy-Kanniappan
Anticancer Research|December 26, 2012
Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targetingShanmugasundaram Ganapathy-Kanniappan, Rani Kunjithapatham, Jean-Francois Geschwind
Oncotarget|September 12, 2012
Glyceraldehyde-3-phosphate dehydrogenase: a promising target for molecular therapy in hepatocellular carcinomaShanmugasundaram Ganapathy-Kanniappan, Rani Kunjithapatham, Jean-Francois Geschwind
Cancer Biology & Therapy|December 21, 2012
Statins impair glucose uptake in tumor cellsShanmugasundaram Ganapathy-Kanniappan, Rani Kunjithapatham, Jean-Francois H Geschwind
Biochemistry|January 5, 2005
Role for the alpha-helix in aberrant protein aggregationRani Kunjithapatham, Fabiana Y Oliva, Urmi Doshi, et al.
Oncoimmunology|May 8, 2015
Metabolic perturbation sensitizes human breast cancer to NK cell-mediated cytotoxicity by increasing the expression of MHC class I chain-related A/BDexue Fu, Jean-Francois Geschwind, Swathi Karthikeyan, et al.
Scientific Reports|October 30, 2014
Reversal of anchorage-independent multicellular spheroid into a monolayer mimics a metastatic modelRani Kunjithapatham, Swathi Karthikeyan, Jean-Francois Geschwind, et al.
BMC Research Notes|July 23, 2013
Systemic administration of 3-bromopyruvate reveals its interaction with serum proteins in a rat modelRani Kunjithapatham, Jean-Francois H Geschwind, Pramod P Rao, et al.
Assay and Drug Development Technologies|January 21, 2010
The pyruvic acid analog 3-bromopyruvate interferes with the tetrazolium reagent MTS in the evaluation of cytotoxicityShanmugasundaram Ganapathy-Kanniappan, Jean-Francois H Geschwind, Rani Kunjithapatham, et al.
Radiology|February 24, 2012
Human hepatocellular carcinoma in a mouse model: assessment of tumor response to percutaneous ablation by using glyceraldehyde-3-phosphate dehydrogenase antagonistsShanmugasundaram Ganapathy-Kanniappan, Rani Kunjithapatham, Michael S Torbenson, et al.
Pageof 2